Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Dose Study to Determine the Pharmacokinetic Profiles of Amoxicillin and Clavulanate in Pediatric Patients Receiving Either LP-001 or Augmentin ES-600 Orally

NCT05584683 is registered in ClinicalTrials.gov with Kaizen Bioscience Co. as lead sponsor.

NCT NCT05584683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05584683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Dose Study to Determine the Pharmacokinetic Profiles of Amoxicillin and Clavulanate in Pediatric Patients Receiving Either LP-001 or Augmentin ES-600 Orally
Lead sponsor
Kaizen Bioscience Co.
Phase
Phase 1
Overall status
Completed
Start date
August 9, 2023
Completion date
December 16, 2024
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infections, pediatric